The Latest Breaking News from GME

Bill Gross said on X: "There seems to be a new meme stock every other day now. Most are pump and dump."

There were 87 unusually active put options in Wednesday trading expiring between July 19 and July 26. Three could provide aggressive investors with $1,000 in income over the next month.

After its well-received earnings report, analysts at UBS upgraded Best Buy, predicting more upside ahead for the big-box retailer.

Not surprisingly, GameStop reported terrible Q1 2024 results Friday morning before the open. GME stock was down more than 20% in premarket trading. Thursday, the company's options volume was 1.53 million, 2.8x the 30-day average. That provided lots of unusually active options.

GameStop shares were already lower Friday after an early earnings release and news of another stock offering, but fell further after Roaring Kitty's livestream.

GameStop’s (GME) preliminary first-quarter 2024 results reveal a drop in net sales and significant losses. The retailer faces challenges from reduced demand for physical games and heightened competition from e-commerce giants. Let’s find out if GME can weather the storm and sustain momentum in the gaming sector. Read more.

According to analysts on Wall Street, GameStop and these three other sell-rated stocks remain high-risk investments.

Why did Roaring Kitty return, and what — if anything — does it mean for the future of GameStop’s stock prices?

Meme stocks such as GME and AMC have risen substantially this month. However, due to their weak fundamentals, these companies are high-risk investments.

Amidst robust consumer spending, evolving customer tastes, and rapid digitalization, the specialty retail industry emerges as a hotbed for substantial growth. Now, let's turn our attention to leading specialty retail stocks, GameStop (GME) and Upbound Group (UPBD), dissecting their potential to uncover which of them is the better long-term investment.

The S&P 500 and Dow Jones Industrial Average snapped three-day losing streaks as drugmaker Merck rallied.